Celcuity (CELC) Cash from Operations (2016 - 2025)
Celcuity's (CELC) quarterly Cash from Operations came in at 36399000.0 in Q4 2025, down 31.07% YoY from 52808120.27 in Q4 2024, and up 18.78% on a QoQ basis from 44816000.0 in Q3 2025.
Analysis
Celcuity (CELC) Cash from Operations (2016 - 2025) Analysis & Trends
Celcuity (CELC) has 10 years of Cash from Operations data on file, last reported at 36399000.0 in Q4 2025.
- Quarterly Cash from Operations fell 31.07% year-over-year to 36399000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 153280000.0 (down 83.64% YoY) and the FY2025 annual result came in at 153280000.0, down 83.64% from the prior year.
- Cash from Operations advanced to 36399000.0 in Q4 2025, from 44816000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2521505.0 in Q1 2021 to a low of 44816000.0 in Q3 2025.
- A 5-year average of 17343968.2 and a median of 12807140.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 389.56% — and 2023, when it increased 14.41%.
- Tracing CELC's Cash from Operations over 5 years: stood at 6124002.0 in 2021, then plunged by 54.79% to 9479260.0 in 2022, then plunged by 95.54% to 18535921.0 in 2023, then tumbled by 49.82% to 27770000.0 in 2024, then plunged by 31.07% to 36399000.0 in 2025.
- The last three Cash from Operations figures came in at 36399000.0 (Q4 2025), 44816000.0 (Q3 2025), and 36212000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -36.40 Mn |
| Sep 30, 2025 | -44.82 Mn |
| Jun 30, 2025 | -36.21 Mn |
| Mar 31, 2025 | -35.85 Mn |
| Dec 31, 2024 | -27.77 Mn |
| Sep 30, 2024 | -20.56 Mn |
| Jun 30, 2024 | -18.07 Mn |
| Mar 31, 2024 | -17.07 Mn |
| Dec 31, 2023 | -18.54 Mn |
| Sep 30, 2023 | -12.75 Mn |
| Jun 30, 2023 | -9.66 Mn |
| Mar 31, 2023 | -12.87 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -9.31 Mn |
| Jun 30, 2022 | -11.29 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -6.12 Mn |
| Sep 30, 2021 | -4.05 Mn |
| Jun 30, 2021 | -7.62 Mn |
| Mar 31, 2021 | -2.52 Mn |